vs

Side-by-side financial comparison of Amneal Pharmaceuticals, Inc. (AMRX) and Alliant Energy (LNT). Click either name above to swap in a different company.

Alliant Energy is the larger business by last-quarter revenue ($1.1B vs $722.5M, roughly 1.5× Amneal Pharmaceuticals, Inc.). Alliant Energy runs the higher net margin — 13.4% vs 10.8%, a 2.6% gap on every dollar of revenue. On growth, Alliant Energy posted the faster year-over-year revenue change (9.0% vs 3.9%). Over the past eight quarters, Alliant Energy's revenue compounded faster (1.5% CAGR vs 1.5%).

Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.

Alliant Energy Corporation operates as a utility holding company that provides regulated electricity and natural gas services. It operates through three segments: Utility Electric Operations, Utility Gas Operations, and Utility Other. The company, through its subsidiary, Interstate Power and Light Company (IPL), primarily generates and distributes electricity, and distributes and transports natural gas to retail customers in Iowa; sells electricity to wholesale customers in Minnesota, Illinoi...

AMRX vs LNT — Head-to-Head

Bigger by revenue
LNT
LNT
1.5× larger
LNT
$1.1B
$722.5M
AMRX
Growing faster (revenue YoY)
LNT
LNT
+5.1% gap
LNT
9.0%
3.9%
AMRX
Higher net margin
LNT
LNT
2.6% more per $
LNT
13.4%
10.8%
AMRX
Faster 2-yr revenue CAGR
LNT
LNT
Annualised
LNT
1.5%
1.5%
AMRX

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMRX
AMRX
LNT
LNT
Revenue
$722.5M
$1.1B
Net Profit
$78.0M
$142.0M
Gross Margin
44.3%
85.9%
Operating Margin
19.6%
18.4%
Net Margin
10.8%
13.4%
Revenue YoY
3.9%
9.0%
Net Profit YoY
410.5%
-5.3%
EPS (diluted)
$0.19
$0.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRX
AMRX
LNT
LNT
Q1 26
$722.5M
Q4 25
$814.3M
$1.1B
Q3 25
$784.5M
$1.2B
Q2 25
$724.5M
$961.0M
Q1 25
$695.4M
$1.1B
Q4 24
$730.5M
$975.0M
Q3 24
$702.5M
$1.1B
Q2 24
$701.8M
$894.0M
Net Profit
AMRX
AMRX
LNT
LNT
Q1 26
$78.0M
Q4 25
$35.1M
$142.0M
Q3 25
$2.4M
$281.0M
Q2 25
$22.4M
$174.0M
Q1 25
$12.2M
$213.0M
Q4 24
$-31.1M
$150.0M
Q3 24
$-156.0K
$295.0M
Q2 24
$6.0M
$87.0M
Gross Margin
AMRX
AMRX
LNT
LNT
Q1 26
44.3%
Q4 25
36.5%
85.9%
Q3 25
34.9%
86.3%
Q2 25
39.5%
84.3%
Q1 25
36.8%
86.0%
Q4 24
36.0%
84.7%
Q3 24
38.4%
84.7%
Q2 24
35.6%
83.6%
Operating Margin
AMRX
AMRX
LNT
LNT
Q1 26
19.6%
Q4 25
13.8%
18.4%
Q3 25
9.0%
28.8%
Q2 25
15.4%
23.2%
Q1 25
14.4%
22.8%
Q4 24
10.4%
22.7%
Q3 24
12.6%
29.0%
Q2 24
13.6%
14.5%
Net Margin
AMRX
AMRX
LNT
LNT
Q1 26
10.8%
Q4 25
4.3%
13.4%
Q3 25
0.3%
23.2%
Q2 25
3.1%
18.1%
Q1 25
1.8%
18.9%
Q4 24
-4.3%
15.4%
Q3 24
-0.0%
27.3%
Q2 24
0.9%
9.7%
EPS (diluted)
AMRX
AMRX
LNT
LNT
Q1 26
$0.19
Q4 25
$0.10
$0.54
Q3 25
$0.01
$1.09
Q2 25
$0.07
$0.68
Q1 25
$0.04
$0.83
Q4 24
$-0.10
$0.58
Q3 24
$0.00
$1.15
Q2 24
$0.02
$0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRX
AMRX
LNT
LNT
Cash + ST InvestmentsLiquidity on hand
$197.7M
$556.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$7.3B
Total Assets
$3.5B
$25.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRX
AMRX
LNT
LNT
Q1 26
$197.7M
Q4 25
$282.0M
$556.0M
Q3 25
$201.2M
$753.0M
Q2 25
$71.5M
$329.0M
Q1 25
$59.2M
$25.0M
Q4 24
$110.6M
$81.0M
Q3 24
$74.0M
$827.0M
Q2 24
$43.8M
$92.0M
Total Debt
AMRX
AMRX
LNT
LNT
Q1 26
Q4 25
$2.6B
Q3 25
$2.6B
Q2 25
$2.2B
Q1 25
$2.2B
Q4 24
$2.4B
Q3 24
$2.4B
Q2 24
$2.4B
Stockholders' Equity
AMRX
AMRX
LNT
LNT
Q1 26
Q4 25
$-70.8M
$7.3B
Q3 25
$-109.5M
$7.3B
Q2 25
$-112.1M
$7.1B
Q1 25
$-131.7M
$7.1B
Q4 24
$-109.3M
$7.0B
Q3 24
$-93.4M
$7.0B
Q2 24
$-57.5M
$6.8B
Total Assets
AMRX
AMRX
LNT
LNT
Q1 26
$3.5B
Q4 25
$3.7B
$25.0B
Q3 25
$3.6B
$24.6B
Q2 25
$3.4B
$23.8B
Q1 25
$3.4B
$22.9B
Q4 24
$3.5B
$22.7B
Q3 24
$3.5B
$22.8B
Q2 24
$3.5B
$21.8B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRX
AMRX
LNT
LNT
Operating Cash FlowLast quarter
$269.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.89×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRX
AMRX
LNT
LNT
Q1 26
Q4 25
$130.3M
$269.0M
Q3 25
$118.5M
$408.0M
Q2 25
$83.8M
$243.0M
Q1 25
$7.4M
$249.0M
Q4 24
$118.1M
$254.0M
Q3 24
$141.8M
$351.0M
Q2 24
$39.7M
$255.0M
Free Cash Flow
AMRX
AMRX
LNT
LNT
Q1 26
Q4 25
$108.5M
Q3 25
$106.2M
$-103.0M
Q2 25
$61.0M
$-179.0M
Q1 25
$-5.8M
$-305.0M
Q4 24
$102.9M
Q3 24
$124.8M
$-59.0M
Q2 24
$29.0M
$-137.0M
FCF Margin
AMRX
AMRX
LNT
LNT
Q1 26
Q4 25
13.3%
Q3 25
13.5%
-8.5%
Q2 25
8.4%
-18.6%
Q1 25
-0.8%
-27.0%
Q4 24
14.1%
Q3 24
17.8%
-5.5%
Q2 24
4.1%
-15.3%
Capex Intensity
AMRX
AMRX
LNT
LNT
Q1 26
Q4 25
2.7%
Q3 25
1.6%
42.2%
Q2 25
3.2%
43.9%
Q1 25
1.9%
49.1%
Q4 24
2.1%
Q3 24
2.4%
37.9%
Q2 24
1.5%
43.8%
Cash Conversion
AMRX
AMRX
LNT
LNT
Q1 26
Q4 25
3.72×
1.89×
Q3 25
50.00×
1.45×
Q2 25
3.74×
1.40×
Q1 25
0.61×
1.17×
Q4 24
1.69×
Q3 24
1.19×
Q2 24
6.62×
2.93×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRX
AMRX

Segment breakdown not available.

LNT
LNT

Retail Residential$313.0M29%
Retail Industrial$251.0M24%
Retail Commercial$226.0M21%
Gas$158.0M15%
Other Customer$43.0M4%
Wholesale$36.0M3%
Other Utility$15.0M1%
Steam$9.0M1%

Related Comparisons